TrialAntimicrobial agents and chemotherapy2014

Randomized, placebo-controlled, single-ascending-dose study of BMS-791325, a hepatitis C virus (HCV) NS5B polymerase inhibitor, in HCV genotype 1 infection.

Karen D Sims et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.